Have You Been Diagnosed with Sjogren’s Syndrome
The purpose of the study is to demonstrate clinical efficacy, safety and tolerability of Ianalumab 300mg administered monthly or every 3 months compared to placebo in patients with active Sjogren’s syndrome.
You may qualify to participate in a Sjogren’s study if:
- You are 18 years or older
- Have had a diagnosis of Sjogren’s for 7.5 years or less
All study-related care and medications are at cost.
Compensation of $63 is provided for each completed visit.
After completion of the study, you may enter a 2 year extension study with study medication guaranteed.
To find out more please fill out the form below or call (847) 691-3856